Session » Health Services Research - Poster I

Date: Sunday, November 13, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 89

2015 ACR/ARHP Workforce Study (WFS): Adult Rheumatology Specialists in the United States: Effect of Gender and Generation

9:00AM-11:00AM: Abstract Number: 93

2015 ACR/ARHP Workforce Study in the United States: Adult Rheumatologist Supply and Demand Projections for 2015-2030

9:00AM-11:00AM: Abstract Number: 83

A Qualitative Study Exploring Participants’ Perception of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Maintain Employment

9:00AM-11:00AM: Abstract Number: 91

A Systematic Review of Smartphone Applications for Measuring and Recording Rheumatoid Arthritis Disease Activity

9:00AM-11:00AM: Abstract Number: 99

Academic and Non-Academic Rheumatology: Practice Trends and Common Barriers to Practice from the 2015 ACR/ARHP Workforce Study Survey

9:00AM-11:00AM: Abstract Number: 95

An Analysis of Malpractice Litigation in Rheumatology

9:00AM-11:00AM: Abstract Number: 98

Daily Symptom Reports in a Smartphone-Based Study ‘Cloudy with a Chance of Pain’: Patterns of Attrition over the First Six Months

9:00AM-11:00AM: Abstract Number: 97

Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study

9:00AM-11:00AM: Abstract Number: 85

Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach

9:00AM-11:00AM: Abstract Number: 87

Familiarity Vital for Telemedicine Uptake Among Parents of Pediatric Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 80

Impact of a Patient Support Program on Abandonment of Adalimumab Treatment Initiation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 90

Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 92

Is Patient Support Program (PSP) Participation Associated with Longer Persistence and Greater Adherence Among New Users of Adalimumab?

9:00AM-11:00AM: Abstract Number: 86

Optimizing the Efficiency of Patient Data Capture Using Smartphone Technology: Evaluation of the Correlation Between Promis Instruments for PRO Data Capture

9:00AM-11:00AM: Abstract Number: 100

Patient Support Program for Adalimumab-Treated Patients in Brazil: Impact on Patients’ Adherence and Persistence

9:00AM-11:00AM: Abstract Number: 88

Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance

9:00AM-11:00AM: Abstract Number: 82

Patients with Rheumatoid Arthritis in Germany: Are They Ready for Ehealth Via Mobile Medical Applications?

9:00AM-11:00AM: Abstract Number: 94

Performance of the Patient Reported Outcomes Measurement Information System (PROMIS) Measure for Physical Function in Early RA

9:00AM-11:00AM: Abstract Number: 101

Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System

9:00AM-11:00AM: Abstract Number: 102

The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors

9:00AM-11:00AM: Abstract Number: 96

Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality

9:00AM-11:00AM: Abstract Number: 84

Treatment Outcomes and Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis: Results from a Post-Marketing Observational Study (PMOS)

9:00AM-11:00AM: Abstract Number: 81

Understanding the Importance of a Patient’s Role in the Management of RA: Physician- and Patient-Based Survey

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].